Increased mucosal CD4+ T-cell activation following vaccination with an adenoviral vector in rhesus macaques by I Bukh et al.
POSTER PRESENTATION Open Access
Increased mucosal CD4+ T-cell activation
following vaccination with an adenoviral vector
in rhesus macaques
I Bukh*, R Calcedo, S Roy, DG Carnathan, R Grant, SJ Ratcliffe, JM Wilson, MR Betts
From AIDS Vaccine 2012
Boston, MA, USA. 9-12 September 2012
Background
The possibility that vaccination with Adenoviral vectors
increased mucosal T-cell activation remains a central
hypothesis to explain the potential enhancement of HIV
acquisition within the STEP trial. Modeling this within
rhesus macaques is complicated because human Adeno-
viruses, including Adenovirus type 5 (HAd5), do not
productively infect macaques. We created a vector based
upon a naturally occurring rhesus macaque Adenovirus
(SAdV7) to test whether vaccination with a species-spe-
cific Adenoviral vector enhances mucosal T-cell activa-
tion within the natural host.
Methods
Twelve rhesus macaques were vaccinated 3x intramuscu-
larly with SAdV7 vector. Five HAd5-vaccinated animals
were included as controls. PBMC and rectal biopsies were
obtained at baseline, multiple times post-prime and post-
17 week boost (8x/animal), and post-31 week second
boost (1x/animal). We assessed rectal mucosal lamina pro-
pria and blood for frequency changes of Ad-specific T-cell
responses and T-cell activation levels by measuring IFNg,
TNFa, IL2, CD25, Ki67, CD69, and HLA-DR.
Results
Naturally acquired pre-existing SAdV7-specific CD4+ T-
cells were identified in 10/13 macaques within blood
and/or rectal mucosa. Following intramuscular SAdV7
vaccination, rectal SAdV7-specific CD4+ T-cell responses
increased above baseline in 9/9 animals 2-5 weeks post-
prime, and subsequently contracted. Five weeks post-
prime, 10/12 animals had rectal SAdV7-specific CD4+
T-cell responses ranging from 0.1-16.84%. As expected,
SAdV7-specific CD4+ T-cells expressed CD69 and other
activation markers (but not Ki67). Heightened expression
of CD25, CD69, and HLA-DR was observed on total rec-
tal memory CD4+ T-cells in SAdV7-vaccinated animals,
and maintained 15 weeks after the prime. Interestingly,
upregulation of activation markers in rectal mucosa also
occurred in HAd5-vaccinated animals. No change in acti-
vation was observed in the blood throughout the entire
study.
Conclusion
These results indicate that peripheral vaccination with
an Adenovirus vector can increase the activation of
mucosal CD4+ T-cells providing an experimental model
to further evaluate the role of host-vector interactions
on increased HIV acquisition.
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